[1]
2014. Bevacizumab in Combination with FOLFIRI in the First-Line Treatment of Patients with Advanced Colorectal Cancer: A Single-Institution Experience. Journal of Analytical Oncology. 3, 1 (Jan. 2014),  26–32. DOI:https://doi.org/10.6000/1927-7229.2014.03.01.4.